Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MICHEL VELEZ

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1518132570
CMS profile
249611
Location
ORLANDO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$144,334.65

317 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
Seagen Inc. $62,461.61 48
PUMA BIOTECHNOLOGY, INC. $38,568.35 29
Lilly USA, LLC $36,899.97 36
Novartis Pharmaceuticals Corporation $3,009.13 24
Janssen Biotech, Inc. $211.27 15
Merck Sharp & Dohme LLC $201.62 11
Amgen Inc. $194.19 11
Celgene Corporation $189.39 11
PFIZER INC. $183.57 14
EISAI INC. $174.49 8
Takeda Pharmaceuticals U.S.A., Inc. $144.23 7
E.R. Squibb & Sons, L.L.C. $139.86 8
GENZYME CORPORATION $139.18 7
AstraZeneca Pharmaceuticals LP $132.57 7
Kite Pharma, Inc. $112.12 5
Astellas Pharma US Inc $103.64 6
Incyte Corporation $102.27 6
SANOFI-AVENTIS U.S. LLC $99.95 1
JAZZ PHARMACEUTICALS INC. $87.39 4
Genentech USA, Inc. $86.88 4
Bayer HealthCare Pharmaceuticals Inc. $83.81 4
GlaxoSmithKline, LLC. $78.76 4
Gilead Sciences, Inc. $68.55 3
Boehringer Ingelheim Pharmaceuticals, Inc. $68.14 2
Daiichi Sankyo Inc. $60.45 3
Pharmacyclics LLC, an AbbVie Company $59.62 2
Ipsen Biopharmaceuticals, Inc $57.06 4
EMD Serono, Inc. $52.97 3
Regeneron Healthcare Solutions, Inc. $52.91 3
Alnylam Pharmaceuticals Inc. $51.51 2
Sun Pharmaceutical Industries Inc. $42.25 3
G1 Therapeutics, Inc. $40.74 2
MorphoSys, US Inc. $39.71 2
Myovant Sciences Inc. $38.32 2
Myriad Genetic Laboratories, Inc. $32.50 2
CSL Behring $30.35 2
Adaptive Biotechnologies Corporation $28.76 1
TerSera Therapeutics LLC $24.34 1
EUSA Pharma (US) LLC $23.25 1
Rigel Pharmaceuticals, Inc. $22.22 1
ARRAY BIOPHARMA INC $19.29 1
Alexion Pharmaceuticals, Inc. $18.75 1
Global Blood Therapeutics, Inc. $18.05 1
Agios Pharmaceuticals, Inc. $17.52 1
BeiGene USA, Inc. $17.14 1
AVEO Pharmaceuticals, Inc. $16.69 1
Heron Therapeutics, Inc. $14.99 1
Sobi, Inc $14.32 1

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

317 matching records · $144,334.65 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 317 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 317.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Daiichi Sankyo Inc. $20.3212/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026930866455 CMS
Janssen Biotech, Inc. $18.9812/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026885720963 CMS
Novartis Pharmaceuticals Corporation $83.3312/15/2022 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026894434113 CMS
Astellas Pharma US Inc $15.6512/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026940335897 CMS
Seagen Inc. $19.4212/13/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026904104019 CMS
Kite Pharma, Inc. $29.7612/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026920067399 CMS
Novartis Pharmaceuticals Corporation $17.4812/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026894434105 CMS
Amgen Inc. $18.6012/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026939899405 CMS
CSL Behring $12.9612/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026940891039 CMS
PUMA BIOTECHNOLOGY, INC. $215.4612/08/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026942289595 CMS
PUMA BIOTECHNOLOGY, INC. $336.1212/08/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026942292393 CMS
Merck Sharp & Dohme LLC $17.7612/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026944268583 CMS
PUMA BIOTECHNOLOGY, INC. $4,500.0012/07/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026942292927 CMS
PUMA BIOTECHNOLOGY, INC. $121.8312/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026942300325 CMS
Seagen Inc. $89.0012/06/2022 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026904104025 CMS
Sun Pharmaceutical Industries Inc. $14.9012/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026947854977 CMS
Genentech USA, Inc. $22.7612/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026950716599 CMS
Bayer HealthCare Pharmaceuticals Inc. $18.2711/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026929812505 CMS
Celgene Corporation $21.9011/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026932592585 CMS
Lilly USA, LLC $20.9911/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026918204121 CMS
G1 Therapeutics, Inc. $23.4011/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026954040147 CMS
Novartis Pharmaceuticals Corporation $2,362.5011/28/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026894434067 CMS
Bayer HealthCare Pharmaceuticals Inc. $18.2011/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026930606829 CMS
Seagen Inc. $11.1611/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026904103999 CMS
Novartis Pharmaceuticals Corporation $83.3311/18/2022 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026894434111 CMS
Celgene Corporation $26.9411/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026932592583 CMS
GlaxoSmithKline, LLC. $18.3811/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026944910513 CMS
Amgen Inc. $10.2511/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026939899403 CMS
Janssen Biotech, Inc. $7.9611/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026885720881 CMS
Seagen Inc. $15.9511/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026904103997 CMS
Genentech USA, Inc. $12.3111/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026950741259 CMS
Gilead Sciences, Inc. $21.7111/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026929592547 CMS
Lilly USA, LLC $2,500.0011/14/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026918227607 CMS
Lilly USA, LLC $2,200.0011/14/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026918241025 CMS
Celgene Corporation $15.4711/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026932592587 CMS
PUMA BIOTECHNOLOGY, INC. $557.2111/11/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026942292389 CMS
PUMA BIOTECHNOLOGY, INC. $4,500.0011/11/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026942299981 CMS
Lilly USA, LLC $816.6611/10/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026918204119 CMS
Lilly USA, LLC $17.0611/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026918204123 CMS
Lilly USA, LLC $538.5111/10/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026918205315 CMS
PFIZER INC. $11.6911/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026949433487 CMS
Seagen Inc. $599.7111/09/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026904103867 CMS
Seagen Inc. $8,140.0011/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026904103869 CMS
Seagen Inc. $221.3111/09/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026904103871 CMS
Seagen Inc. $90.4211/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026904104027 CMS
Seagen Inc. $1,219.2011/09/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026904104029 CMS
Seagen Inc. $21.2411/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026904103995 CMS
Novartis Pharmaceuticals Corporation $19.0611/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026894434103 CMS
GlaxoSmithKline, LLC. $23.9411/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026944910515 CMS
Rigel Pharmaceuticals, Inc. $22.2211/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026962280869 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $96,317.58 176
PY2020 $57,053.29 99
PY2021 $141,505.70 266
PY2022 $144,334.65 317
PY2023 $254,717.41 222
PY2024 $128,817.64 252
PY2025 $104,528.31 222

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
MICHEL VELEZ, NPI 1518132570. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1518132570.
APA 7
IndustryPayments. (2026). MICHEL VELEZ, NPI 1518132570 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1518132570
Bluebook
MICHEL VELEZ, NPI 1518132570, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1518132570.

Source: Centers for Medicare & Medicaid Services, Open Payments.